Find your PDFs fast.
Welcome to the Pubget Medical Subject Headings (MESH) browser. Click on a topic or subtopic below to explore related papers. In the gold box is the most recent paper about the current MESH term, and below are 20 related papers.
Pituitary Diseases (6):
Recent article
Pituitary Diseases
Abstract
Pituitary apoplexy is well known as the first manifestation of pituitary tumour. Conversely, haemorrhage of a pituitary adenoma, revealed by anticoagulant therapy, is very uncommon. Two weeks after initiation of anticoagulant therapy for a deep venous thrombosis, an 83-year-old woman presented with...
|
PMID: 20627475
PDF is available here.
PDF is available here.
| < More recent | Older article > |
Abstract
Diseases of the pituitary gland can lead to the dysfunction of individual hormonal axes and to the corresponding clinical manifestations. The diagnostic assessment of pituitary function has not yet been standardized.
The members of the Neuroendocrinology Section and the Pituitary Study Group of the...
|
PMID: 20644702
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Endocrine Reviews (31)3 2010
Abstract
Pituitary disease is associated with increased mortality predominantly due to vascular disease. Control of cortisol secretion and GH hypersecretion (and cardiovascular risk factor reduction) is key in the reduction of mortality in patients with Cushing's disease and acromegaly, retro...
|
PMID: 20086217
PDF is available here.
PDF is available here.
Abstract
The insulin tolerance test (ITT) is considered the gold standard for assessment of GH and ACTH reserve in patients with pituitary disease following pituitary surgery and is usually performed after 6-12 weeks. However, abnormal axes may not be completely recovered by then. The aim of...
|
PMID: 20207728
PDF is available here.
PDF is available here.
Abstract
The most significant corporal change observed in adolescent girls is the onset of menstruation, which occurs between 12 and 13 years of age. In several cases, described with the term 'precocious puberty', pubertal development can begin at a significantly younger age. The term 'delayed puberty' refer...
|
PMID: 20034856
PDF is available here.
PDF is available here.
Abstract
These results show that TSS is an effective treatment for canine Cushing's disease and for long-term improvement of hypercortisolemia. Moreover, TSS is effective in improvement of hypercortisolism, such as increased concentrations of serum ALP, ALT and total cholesterol....
|
PMID: 19996557
PDF is available here.
PDF is available here.
Abstract
We present an unusual outcome of long term GnRHa therapy in two girls with central precocious puberty(CPP) of idiopathic or organic origin. They have received monthly depot injections of triptorelin acetate for a time period of 8 years. Thyroid function was examined by measuring serum levels of thyr...
|
PMID: 20583547
PDF is available here.
PDF is available here.
Abstract
We therefore evaluated the clinical applicability of GHRP6, which is a known activator of the hypothalamic-pituitary-adrenal (HPA) axis, to test for AI. For this purpose a comparative clinical study was designed. Forty-nine patients with suspected dysfunction of the HPA axis and 20 healthy controls...
|
PMID: 19946832
PDF is available here.
PDF is available here.
Mayo Clinic Proceedings (85)2 2010
Abstract
Abstract
Horses with PPID had higher fecal egg counts before and 8, 10, and 12 weeks after ivermectin treatment, compared with counts for site-matched healthy horses. There was no difference in the period for < 90% reduction in fecal egg counts between the 2 groups. Age did not affect fecal egg counts at any...
|
PMID: 20113248
PDF is available here.
PDF is available here.
Abstract
Abstract
In this article, we describe the recent studies on pathophysiology of the muscular skeletal complaints in endocrine disease. In addition we report on population as well as genetic studies, which address the relationship between endocrine and rheumatologic disease, both of which are autoimmune. SUMMA...
|
PMID: 19935068
PDF is available here.
PDF is available here.
Abstract
We demonstrate how to extract proteins from mouse pituitary glands and how to prepare them in a form suitable for inducing autoimmune hypophysitis in SJL mice....
|
PMID: 21206466
PDF is available here.
PDF is available here.
Abstract
We report on a man with a progressively increasing pituitary mass, as demonstrated by MRI. It produced neurological and ophthalmological symptoms, and, ultimately, hypopituitarism. MRI also showed enlargement of the pituitary stalk and a dural tail phenomenon. An increased titer of antipituitary ant...
|
PMID: 20098956
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Abstract
We review here key aspects of diagnosis and treatment of anti-CTLA-4 antibody therapy resultant IRAEs. We describe the first two cases of hypopituitarism in prostate cancer subjects undergoing experimental therapy with ipilimumab. The clinical evidence strongly suggests that the prostate cancer subj...
|
PMID: 19639414
PDF is available here.
PDF is available here.
Endocrine Journal (57)6 2010
Abstract
We made a diagnosis of IgG4-related systemic disease. Interestingly, a subsequent MRI scan at three weeks after the patient commenced glucocorticoid replacement therapy for adrenal insufficiency showed that the swelling of his pituitary stalk was reduced. This finding suggested that IgG4-related hyp...
|
PMID: 20371985
PDF is available here.
PDF is available here.
Clinical Neuropathology (29)1 2010
Abstract
Lymphocytic hypophysitis (LYH) is a rare autoimmune inflammatory disorder of the pituitary gland usually affecting young women, often in pregnancy or post partum period. It is rare in non-pregnant females and in men. Patients present with symptoms of an expanding pituitary mass and/or varying degree...
|
PMID: 20040330
PDF is available here.
PDF is available here.
Przeglad lekarski (67)3 2010
Abstract
Pregnancy is associated with a number of changes in endocrine physiology that substantially alter hormone levels and affect a number of disease processes. Consequently, both pregnancy and the postpartum period may influence the course of pre-existing pituitary disorders and lead to the development o...
|
PMID: 20687384
PDF is available here.
PDF is available here.
Abstract
The authors report the first attempt to develop the treatment strategy for patients with primary "empty" sella turcica syndrome based at a health resort facility. It is shown that combined therapy including radon baths and acupuncture at specific auricular points makes it possible to improve functio...
|
PMID: 21086599
PDF is available here.
PDF is available here.
Abstract
BACKGROUND: Pegvisomant is a genetically engineered molecule, which exhibits specific growth hormone (GH) antagonism by directly interacting with the GH receptor. It is currently licensed for the treatment of acromegaly where surgery and medical therapy with somatostatin analogues have failed. OBJEC...
|
PMID: 19916734
PDF is available here.
PDF is available here.
Abstract
Log ACTH concentration was increased during photoperiod 4 through 8, compared with photoperiod 1 through 3, in all groups. In photoperiod 3 through 7, log ACTH concentrations were higher in horses and ponies with PPID, compared with values for control horses and ponies. alpha-Melanocyte-stimulating...
|
PMID: 19751169
PDF is available here.
PDF is available here.
Clinical Medicine (9)4 2009
Abstract
Acta Neurochirurgica (151)7 2009
Abstract
Having just celebrated the centenary of the first transsphenoidal pituitary operation by (Schloffer in Austria in Beitr Klin Chir 50:767-817, 1906), and this year the quarter centenary of the first published report of a therapeutic use of the neuroendoscope (for colloid cysts of the third ventricle)...
|
PMID: 19387542
PDF is available here.
PDF is available here.
Journal de Radiologie (90)6 2009
Abstract
Normal anatomical structures and lesions characterized by low T2W signal intensity are reviewed in this pictorial essay. The purpose is to demonstrate how evaluation of the appearance, shape and exact anatomical location of the T2W hypointense sellar region structure, correlated with its T1W signal...
|
PMID: 19623122
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
Brain and Development (31)6 2009
Abstract
We examined hypothalamic dysfunctions in a XLAG case with a novel mutation of the ARX gene, and performed immunohistochemical evaluation of the diencephalons in autopsy brain. A 1-year-old boy showed intractable epilepsy, persistent diarrhea and disturbed temperature regulation. This case had abnorm...
|
PMID: 18842366
PDF is available here.
PDF is available here.
European Radiology (19)5 2009
Abstract
We review the CT appearances of tumours resulting in covert EAS and the associated literature. The most common tumours were bronchial carcinoid tumours, which appear as small, well-defined, round or ovoid pulmonary lesions. Rarer causes included thymic carcinoids, gastrointestinal carcinoids and pan...
|
PMID: 19137302
PDF is available here.
PDF is available here.
Abstract
The median baseline and peak cortisol attained with hypoglycemia were 284 (164-323) and 473.5 (366-494) nmol/liter, respectively. A strong positive correlation was seen between peak stimulated cortisol and CPR (adjusted for body surface area) (r = 0.75; P = 0.02), and in all patients CPR [4.6 (2.9-1...
|
PMID: 19240150
PDF is available here.
PDF is available here.